News (Media Awareness Project) - Australia: Hep C Drives Needle Need |
Title: | Australia: Hep C Drives Needle Need |
Published On: | 1999-05-20 |
Source: | Illawarra Mercury (Australia) |
Fetched On: | 2008-09-06 05:58:31 |
HEP C DRIVES NEEDLE NEED
The hepatitis C epidemic in Australia should give impetus to the NSW
Government to properly resource needle and syringe programs, lobbyists said
yesterday.
Hepatitis C Council of NSW executive officer Stuart Loveday said the drug
summit should come up with resolutions focusing on reduction of blood-borne
diseases.
Mr Loveday said with 30 new hepatitis C infections in Australia every day,
the disease was the fastest-spreading blood-borne infection. Most cases
were caused by people sharing equipment used to inject illicit drugs.
``Needle and syringe programs have proved to be a spectacular success in
preventing an HIV epidemic among people who inject drugs,'' he said.
``Evidence shows that existing programs have substantially lowered
hepatitis C prevalence rates among people new to drug injecting.''
He said needle and syringe programs had prevented 2000 hepatitis C
transmissions each year.
The hepatitis C epidemic in Australia should give impetus to the NSW
Government to properly resource needle and syringe programs, lobbyists said
yesterday.
Hepatitis C Council of NSW executive officer Stuart Loveday said the drug
summit should come up with resolutions focusing on reduction of blood-borne
diseases.
Mr Loveday said with 30 new hepatitis C infections in Australia every day,
the disease was the fastest-spreading blood-borne infection. Most cases
were caused by people sharing equipment used to inject illicit drugs.
``Needle and syringe programs have proved to be a spectacular success in
preventing an HIV epidemic among people who inject drugs,'' he said.
``Evidence shows that existing programs have substantially lowered
hepatitis C prevalence rates among people new to drug injecting.''
He said needle and syringe programs had prevented 2000 hepatitis C
transmissions each year.
Member Comments |
No member comments available...